1. Home
  2. DNLI vs GPOR Comparison

DNLI vs GPOR Comparison

Compare DNLI & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • GPOR
  • Stock Information
  • Founded
  • DNLI 2013
  • GPOR 1997
  • Country
  • DNLI United States
  • GPOR United States
  • Employees
  • DNLI N/A
  • GPOR N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • GPOR Oil & Gas Production
  • Sector
  • DNLI Health Care
  • GPOR Energy
  • Exchange
  • DNLI Nasdaq
  • GPOR Nasdaq
  • Market Cap
  • DNLI 3.1B
  • GPOR 3.5B
  • IPO Year
  • DNLI 2017
  • GPOR N/A
  • Fundamental
  • Price
  • DNLI $20.73
  • GPOR $185.10
  • Analyst Decision
  • DNLI Strong Buy
  • GPOR Buy
  • Analyst Count
  • DNLI 13
  • GPOR 7
  • Target Price
  • DNLI $37.91
  • GPOR $210.00
  • AVG Volume (30 Days)
  • DNLI 814.8K
  • GPOR 206.3K
  • Earning Date
  • DNLI 03-04-2025
  • GPOR 02-25-2025
  • Dividend Yield
  • DNLI N/A
  • GPOR N/A
  • EPS Growth
  • DNLI N/A
  • GPOR N/A
  • EPS
  • DNLI N/A
  • GPOR 11.88
  • Revenue
  • DNLI N/A
  • GPOR $886,642,000.00
  • Revenue This Year
  • DNLI N/A
  • GPOR $1.87
  • Revenue Next Year
  • DNLI $289.18
  • GPOR $35.02
  • P/E Ratio
  • DNLI N/A
  • GPOR $15.58
  • Revenue Growth
  • DNLI 204.74
  • GPOR N/A
  • 52 Week Low
  • DNLI $14.56
  • GPOR $130.02
  • 52 Week High
  • DNLI $33.33
  • GPOR $201.18
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.56
  • GPOR 50.48
  • Support Level
  • DNLI $21.33
  • GPOR $181.01
  • Resistance Level
  • DNLI $22.81
  • GPOR $196.18
  • Average True Range (ATR)
  • DNLI 1.27
  • GPOR 5.35
  • MACD
  • DNLI -0.10
  • GPOR 0.31
  • Stochastic Oscillator
  • DNLI 15.83
  • GPOR 39.59

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition and production of natural gas, crude oil and NGL in the United States. It operates through Utica Shale and Scoop properties. The Utica Shale is located in the Appalachian Basin of the United States and Canada. The Scoop (South Central Oklahoma Oil Province) play of Oklahoma is located in the southeast portion of the prolific Anadarko Basin.

Share on Social Networks: